Core Viewpoint - The article discusses the establishment of pilot testing platforms for biomanufacturing, focusing on key product areas such as food additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations, with a goal to support innovation and commercialization in the industry [1][2]. Group 1: Pilot Testing Platforms - The Ministry of Industry and Information Technology and the National Development and Reform Commission aim to cultivate over 20 pilot testing platforms by 2027, serving more than 200 enterprises and incubating over 400 products [1]. - The initiative emphasizes market-driven and demand-led approaches, encouraging national laboratories and innovation platforms to develop pilot testing capabilities [1][2]. - The platforms will focus on addressing the shortcomings and pain points in the pilot testing phase of biomanufacturing, particularly in the development of new raw materials such as lignocellulosic and one-carbon compounds [2]. Group 2: Guidelines and Events - The article includes attachments such as the "Biomanufacturing Pilot Testing Capability Construction Platform Cultivation Guidelines (2025 Edition)" and an application form for the platform [3]. - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) is scheduled for August 20-22 in Jinan, Shandong, aiming to discuss trends in biomanufacturing and promote technology transfer and commercialization [4].

Group 1: Core Insights - The article introduces the "Global Bio-based Industry Monthly Report," providing insights into the latest trends and opportunities in the bio-based sector [1][2][3] - The report is available for free to industry peers, highlighting the importance of collaboration and information sharing within the bio-based industry [1][3] Group 2: Policy Releases - The report includes three domestic bio-based related policies, emphasizing projects focused on carbon reduction and sustainable materials [7][19] - Key projects mentioned include a 110,000-ton biodegradable polyester rubber demonstration project and a 1 million-ton sustainable aviation fuel project [8][19] Group 3: Industry Dynamics - The report details two domestic bio-based chemical company updates, including a 120 million yuan investment in a lactic acid production demonstration line [9][10] - It also highlights the establishment of a new company focused on food additives, indicating growth in the bio-based chemicals sector [10] Group 4: Capital Events - The report outlines several financing events in the bio-based sector, including a multi-million yuan investment in a company specializing in bio-based high barrier film materials [11][22] - Notable investments include over 100 million yuan in a company focused on recombinant collagen and near 100 million yuan in a company producing bioactive ingredients [22] Group 5: Scientific Research Progress - The report presents significant research breakthroughs in the bio-based field, such as the development of a new method for synthesizing high-order carbohydrates from low-carbon molecules [12][23] - It also discusses advancements in bioremediation techniques using engineered bacteria to address environmental pollution [12][23] Group 6: Upcoming Events - The "Fourth Synthetic Biology and Green Bio-manufacturing Conference" is scheduled for August 20-22, 2025, in Jinan, Shandong, focusing on the future of bio-manufacturing [25][26] - The conference aims to foster collaboration among industry leaders, researchers, and investors to explore innovative technologies and applications in the bio-manufacturing sector [25]

Project Overview - The project is named "Baikaiseng (Jiangsu) Biotechnology Co., Ltd. New Green Biosynthesis Industrialization Project" with a total investment of 120 million yuan, including 6.13 million yuan for environmental protection [2] - The project will be located in Lianyungang City, Jiangsu Province, covering an area of 29,597 square meters (approximately 44.39 acres) [2] - Construction is planned to start in June 2025 and be completed by December 2025 [2] Production Capacity and Products - The project will establish an automated flexible fermentation production line with a total annual production capacity of: - Squalene: 180 tons - Ergothioneine: 10 tons - Rebaudioside M: 50 tons - Valencene: 20 tons - Ectoine: 40 tons [2][3] - The production lines will operate for varying hours annually, with Squalene production running for 4,728 hours and Ergothioneine for 600 hours [3] Product Applications - Squalene: Used as a dietary supplement to improve fatigue and enhance immunity, suitable for high-pressure or hypoxic environments [5] - Ergothioneine: A natural antioxidant used as a dietary supplement with anti-inflammatory and neuroprotective effects [6] - Ectoine: A natural amino acid derivative with antioxidant and anti-inflammatory properties, aiding in post-exercise recovery [6] - Rebaudioside M: A natural sweetener derived from stevia, approved as a food additive, suitable for various food and beverage applications [6][7] - Valencene: A food additive used to enhance citrus aroma in food products [7] Company Background - Baikaiseng (Jiangsu) Biotechnology Co., Ltd. is a subsidiary of Baikaiseng (Shanghai) Biotechnology Co., Ltd., established on March 15, 2024 [8] - The company focuses on the research and development of biomanufacturing technologies across pharmaceuticals, cosmetics, and food sectors [8]

【SynBioCon】 获 悉，近日， 诺泰生物 （688076.SH）与 诺唯赞生物 （688105.SH）战略签约，合作 成立合资公司，共同推进双方在 合成生物学领域 的业务发展。 这是诺泰生物在小分子技术平台，多肽技术平台和寡核苷酸技术平台的基础上，拓展建设的 合成生物学技 术平台 。公司高度重视科技平台的建设和创新，通过学科交叉推行平台战略，实现产业升级，扩大公司在 医药产品的技术和生产优势，巩固和提升在细分领域的领先地位。 此次战略合作的达成，不仅是诺泰生物（688076.SH）与诺唯赞生物（688105.SH）在业务拓展和技术创新 方面的重要一步，也为整个生物科技行业带来了新的发展机遇。期待双方未来在合成生物学领域内的探索 不仅能在生物医药领域产生重大影响力，还可以在 动物保健 与 农业 等更多领域产能较强的影响力。 合资 公司由诺泰生物控股 。 生物合成是生物学研究的前沿领域，以生物酶作为催化剂为核心。与传统化学反应相比， 生物酶催化展现 出诸多显著优势，如绿色无害、安全性高、特异性极强以及原子经济性高等。 （ Source: 《生物革命：创新改变了经济、社会和人们的生活——麦肯锡全球研究院》（ ...

Group 1: Policy Release - The report includes three domestic policies related to the bio-based industry [7][18]. - Key projects in the policies focus on carbon reduction and include initiatives for biodegradable polyester rubber, high-performance bio-based materials, and sustainable aviation fuel [8][19]. Group 2: Industry Dynamics - The report highlights two domestic developments in the bio-based chemicals sector, including a project for lactic acid production and the establishment of a new company for food additives [9][20]. - A total of 13 domestic developments in the bio-manufacturing sector are reported, including strategic collaborations and new project announcements [20][21]. Group 3: Capital Events - Several financing events in the bio-based sector are noted, with companies raising millions in funding for various bio-manufacturing projects [11][22]. - Notable investments include over 100 million yuan for recombinant collagen and nearly 100 million yuan for bioactive ingredients [22]. Group 4: Scientific Research Progress - Significant breakthroughs in scientific research related to bio-based materials and manufacturing are reported, including advancements in bioremediation and the synthesis of high-order carbohydrates [12][23]. - Research highlights include the development of engineered bacteria for pollutant degradation and innovative methods for synthesizing sugars from low-carbon molecules [23]. Group 5: Upcoming Events - The fourth Synthetic Biology and Green Bio-Manufacturing Conference is scheduled for August 20-22, 2025, in Jinan, Shandong, focusing on industry trends and technological innovations [25][26].

Core Viewpoint - The article discusses the intensifying global competition for carbon neutrality and how the bio-based industry can address three major contradictions: reliance on upstream raw materials, certification barriers in the midstream, and limitations in downstream applications [1] Group 1: Event Overview - A closed-door meeting focused on industry breakthroughs was held from May 25-27 during the 2025 Bio-based Conference and Exhibition in Shanghai [4] - The "2025 Bio-based Industry Strategic Seminar" was co-hosted by DT New Materials and the Zhoushan Investment Promotion Center [4] - 25 representatives from industry associations, well-known brands, material companies, and research institutions gathered to discuss three core topics: market reshaping, policy collaboration, and technological breakthroughs [6] Group 2: Key Insights from the Opening Report - The opening report emphasized that bio-based materials are a core pathway for the chemical industry to achieve sustainable development [8] - It highlighted that China's "dual carbon" policy is accelerating implementation, with industry associations promoting collaborative development through policy recommendations, standard setting, and technological rewards [8] Group 3: Brand User Demands - Certification and traceability have become essential prerequisites for collaboration, with international brands requiring non-food bio-based raw material certification [10] - Brands are generally willing to accept a price increase of up to 10%, but significant cost increases could hinder market promotion [11] - Performance must be contextualized, with specific demands for lightweight and decorative bio-based materials in automotive parts and integrated packaging solutions in cosmetics [11] Group 4: Strategies for Bio-based Material Companies - The industrialization of FDCA (2,5-furandicarboxylic acid) faces challenges, with current prices being 40 times that of PTA, making large-scale production crucial for cost reduction [14] - Companies need to identify unique value scenarios beyond merely replacing petroleum-based materials [14] - There is a call for policy collaboration to align with the EU's Packaging and Packaging Waste Regulation (PPWR) and to develop a bio-based materials standard system in China [14] Group 5: AI Empowerment in Bio-manufacturing - Companies shared practices of using AI to reduce R&D costs by 30% through protein modification, enhancing enzyme efficiency, and shortening development cycles [16] - Addressing purity issues is critical for high-end applications, with a need for collaboration across the entire supply chain [16] Group 6: Zhoushan's Strategic Positioning - Zhoushan aims to become a new hub for the bio-based industry by attracting projects related to PLA, PHA, FDCA-PEF, and other materials, providing comprehensive support [17] - The region has already gathered benchmark companies, indicating an initial scale of the industry chain ecosystem [17] Group 7: Consensus on Industry Collaboration - The meeting reached three core conclusions: 1. Non-food raw materials are essential for large-scale commercialization, requiring dual drivers of policy and technological innovation [20] 2. Accelerating the establishment of carbon footprint standards aligned with international norms is necessary to break down green trade barriers [20] 3. Collaboration between brands and material suppliers is needed to shift from performance substitution to value creation [20] - The meeting emphasized that bio-based materials represent a shift in competition rather than a shortcut, necessitating collective efforts across the entire industry chain to overcome the "valley of death" from laboratory to large-scale production [20]

Core Viewpoint - The establishment of the American Bio-Manufacturing Alliance (AAB) aims to enhance the U.S. bio-manufacturing capabilities, promote domestic innovation, and increase the country's influence in the rapidly growing global bio-economy [1][2] Group 1: Alliance Formation - The AAB was formed on May 21, 2023, and includes stakeholders from the bio-manufacturing sector, such as CEOs from Manus, Pivot Bio, Novonesis North America, Kula Bio, and LanzaTech Global [1] - The formation of the alliance follows a call from the emerging biotechnology national security council (NSCEB) for a coordinated national strategy to strengthen U.S. leadership in the field [1] Group 2: Objectives of AAB - AAB has two main objectives: to increase demand for bio-based products and technologies in the U.S. and to ensure a comprehensive market for existing and emerging bio-products [2] - Founding members highlighted the economic and environmental potential of bio-manufacturing, emphasizing the development of low-cost, high-performance agricultural inputs to reduce reliance on global supply chains [2] Group 3: Industry Impact - Bio-manufacturing is applicable across various sectors, including agriculture, energy, chemicals, materials, nutrition, and pharmaceuticals, utilizing biological materials to produce sustainable products [1] - The global bio-manufacturing market is currently valued at $20 billion and is expected to experience significant growth over the next decade [1]

Core Insights - The 10th Bio-based Conference and Exhibition was held in Shanghai from May 26-27, 2025, focusing on AI-enabled innovation in new materials and applications in bio-based materials [1][3][19] - The conference featured discussions on the development trends of the bio-manufacturing industry in China, highlighting its potential as a global bio-manufacturing center [3] - Various experts presented on the integration of AI in chemical new materials research and production, emphasizing the challenges and opportunities in this field [7][16] Group 1: Industry Trends and Insights - YiKai Capital's partner shared insights on the definition and market size of the global and Chinese bio-manufacturing industry, along with development trends and capital market reviews for 2024 and 2025 [3] - The Shanghai Academy of Science's researcher discussed a dual-driven molecular pre-training model that significantly improved reaction selectivity by five times and designed new biodegradable polymer materials [5] - The roundtable discussions included perspectives from investment institutions and scientific experts on how AI can enhance the efficiency of bio-based material research and development [9][15] Group 2: AI Applications in Material Science - The market director of Magnesium Technology presented on the application of AI in the research and production of chemical new materials, addressing the challenges faced in implementing these technologies [7] - A report on high-resolution atomic imaging analysis using deep learning highlighted the limitations of traditional models and introduced a new framework for analyzing structural diversity [11] - The application of AI in polymer material design was discussed, showcasing recent advancements and case studies in composite materials and organic photovoltaic materials [13]

Core Insights - The Guangdong food industry is experiencing a transformation through the integration of artificial intelligence and data management, enhancing productivity and efficiency [1][4][5] - The "2025 Food Season" initiative aims to stimulate domestic demand and promote the transformation of the food industry in Guangdong [3][4] Group 1: Industry Development - Guangdong's food industry is projected to generate nearly 900 billion yuan in revenue by 2024, ranking among the top in the country [2] - The province has established a "One Area, One Belt, All-Around Support" industrial development framework, with major cities like Guangzhou, Foshan, and Dongguan each exceeding 100 billion yuan in food industry scale [2] - As of now, there are 25 provincial food industrial pilot counties, with 48% of the counties recognized for their innovative and competitive practices [2] Group 2: Technological Integration - The application of AI across the food production chain is set to optimize resource allocation and improve management efficiency [4][5] - Notable advancements include the establishment of a digital intelligent demonstration factory by Jianlibao in Foshan, which has improved capacity utilization by 16% and reduced costs by 14% [4] - Hai Tian's factory has been recognized as a world-class "Lighthouse Factory," utilizing an "AI electronic nose" to standardize flavor profiles in soy sauce production [5] Group 3: Regional Specialization - Different pilot counties are developing unique industrial paths, such as Meizhou's focus on selenium-rich and longevity foods, generating over 3 billion yuan annually [2] - Chaozhou's production of salted chicken has established a complete industry chain, capturing over 80% of the national market share for its products [2] - Huizhou's Borou County has transitioned from raw material sales to a comprehensive industry chain, supported by a 5 billion yuan investment in agricultural processing [3]

Core Insights - The article emphasizes the importance of biomanufacturing as a new industry that leverages biological functions for large-scale material processing and transformation, contributing to industrial goods for societal development [1] - Hubei province aims to advance technological and industrial innovation by balancing the transformation of traditional industries with the cultivation of emerging and future industries [1] Group 1: Biomanufacturing Development in Hubei - Hubei has a solid foundation for developing biomanufacturing, supported by its strong biological industry and innovation capabilities [2] - The province has 11.5 million biopharmaceutical companies and 36,452 biopharmaceutical patents, with Wuhan housing 42,080 biopharmaceutical companies and 19,791 patents [2] - Biomanufacturing is seen as a new growth point for Hubei's biological industry, creating new materials and ensuring sustainable production methods [2][3] Group 2: Educational and Research Initiatives - Hubei University is focusing on enhancing its capabilities in synthetic biology and biomanufacturing to support the province's industrial layout [3] - The university is investing in talent, platforms, and research to address the bottlenecks in industrial transformation and to develop core technologies in biomanufacturing [3][5] - Hubei University has established a synthetic biology innovation consortium with leading enterprises to drive the development of biomanufacturing in the region [3] Group 3: Strategic Planning and Integration - Hubei's future biomanufacturing development should align with China's modernization goals, focusing on economic and social benefits [4] - The province plans to create a 5-10 year development plan for biomanufacturing, emphasizing foundational biotechnology upgrades and high-value biological product development [4][5] - The strategy includes attracting leading companies in the biomanufacturing sector to enhance resource integration and support the growth of related academic disciplines [5]